In this section, you will learn about bispecific antibodies that are not yet commercially available. However, we already have some initial results regarding their effectiveness and safety. Certain myeloma patients whose disease meets specific criteria can access these therapies through clinical trials.
Multiple myeloma research is constantly evolving, and clinical trials play a crucial role in this progress. They allow doctors to test and evaluate the safety and effectiveness of promising new therapies like bispecific antibodies.
Clinical trials are research studies that involve volunteers to test new medications, treatment approaches, or medical devices. They are carefully designed and conducted by healthcare professionals to ensure patient safety and gather reliable data.
Patients with myeloma may have the opportunity to participate in trials investigating various aspects of the disease, including:
To learn more about clinical research, visit our HealthTree University unit about clinical trials in multiple myeloma.
Finding a clinical trial that you qualify for can be tricky! Read the suggestions below on how to find one.